Amitai, I.; Magen, H.; Leader, A.; Pironet, A.; Tousset, E.; Rozental, A.; De Geest, S.; Vaxman, I.; Raanani, P.; Nagler, A.
High Implementation Adherence to Lenalidomide in Multiple Myeloma. Cancers 2025, 17, 3587.
https://doi.org/10.3390/cancers17213587
AMA Style
Amitai I, Magen H, Leader A, Pironet A, Tousset E, Rozental A, De Geest S, Vaxman I, Raanani P, Nagler A.
High Implementation Adherence to Lenalidomide in Multiple Myeloma. Cancers. 2025; 17(21):3587.
https://doi.org/10.3390/cancers17213587
Chicago/Turabian Style
Amitai, Irina, Hila Magen, Avi Leader, Antoine Pironet, Eric Tousset, Alon Rozental, Sabina De Geest, Iuliana Vaxman, Pia Raanani, and Arnon Nagler.
2025. "High Implementation Adherence to Lenalidomide in Multiple Myeloma" Cancers 17, no. 21: 3587.
https://doi.org/10.3390/cancers17213587
APA Style
Amitai, I., Magen, H., Leader, A., Pironet, A., Tousset, E., Rozental, A., De Geest, S., Vaxman, I., Raanani, P., & Nagler, A.
(2025). High Implementation Adherence to Lenalidomide in Multiple Myeloma. Cancers, 17(21), 3587.
https://doi.org/10.3390/cancers17213587